2024-11-18 18:40:38
Innovent Biologics Announces First Patient Dosed in the Pivotal Registrational Trial of Pemigatinib in Patients with Advanced Cholangiocarcinoma in China
Corporate/ 2023-07-23
Innovent Biologics Announces First Patie...

SUZHOU,China,March 4,2020--Innovent Biologics,Inc. ("Innovent" or "the Company") (HKEX: 01801),a world-class biopharmace...

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Corporate/ 2023-07-23
Samsung Biologics and STCube Enter into ...

SONGDO,South Korea,March 3,2020--Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreem...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release